Geoff Meacham
Stock Analyst at Citigroup
(3.84)
# 643
Out of 4,955 analysts
255
Total ratings
57.14%
Success rate
6.39%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Neutral | $305 → $310 | $296.45 | +4.57% | 13 | Aug 6, 2025 | |
| BIIB Biogen | Maintains: Neutral | $125 → $135 | $138.99 | -2.87% | 15 | Aug 1, 2025 | |
| PTCT PTC Therapeutics | Maintains: Neutral | $40 → $50 | $48.85 | +2.35% | 9 | Jul 28, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $79 → $78 | $53.07 | +46.98% | 3 | Jul 22, 2025 | |
| RPRX Royalty Pharma | Maintains: Buy | $40 → $42 | $36.88 | +13.88% | 3 | Jul 22, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $48.88 | +10.47% | 6 | Jun 25, 2025 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $56.23 | +28.05% | 1 | Jun 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $42 | $24.32 | +72.70% | 1 | Jun 17, 2025 | |
| ACLX Arcellx | Initiates: Buy | $110 | $71.51 | +53.82% | 1 | Jun 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $12 | $8.03 | +49.44% | 2 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.41 | +183.69% | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $8.74 | -31.35% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $75 | $44.34 | +69.15% | 6 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $650 | $591.01 | +9.98% | 22 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $210 → $205 | $209.15 | -1.98% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $42.35 | +3.90% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $111.30 | +25.79% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $1.61 | -37.89% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $26.89 | +48.75% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $33.21 | +20.45% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $36.02 | +163.74% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $9.10 | +174.73% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $57.96 | +77.71% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $5.04 | -20.63% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $118.73 | +5.28% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $394.36 | +45.81% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $705.44 | +55.93% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $10.65 | +87.79% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $10.24 | +202.73% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $84.66 | +71.27% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $178.84 | -4.94% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $24.87 | +93.00% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $48.26 | +24.33% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $4.36 | +221.10% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.45 | +46.79% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.53 | +3,110.58% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $25.38 | +77.30% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.85 | +1,197.30% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $4.19 | -4.53% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.46 | +1,817.81% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.55 | +6,138.53% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $8.52 | +557.28% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $2.05 | +1,607.32% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.38 | +15,433.00% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.48 | +2,737.84% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $7.56 | +164.55% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.54 | +3,603.70% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $5.11 | +76.13% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $8.07 | +643.49% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.32 | +62.04% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $14.32 | +60.61% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $86.20 | -4.87% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $306.48 | -69.00% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.80 | +716.33% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $133.23 | +1.33% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.52 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $1.10 | +1,718.18% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $14.70 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $458.31 | -65.53% | 5 | Nov 8, 2017 |
Amgen
Aug 6, 2025
Maintains: Neutral
Price Target: $305 → $310
Current: $296.45
Upside: +4.57%
Biogen
Aug 1, 2025
Maintains: Neutral
Price Target: $125 → $135
Current: $138.99
Upside: -2.87%
PTC Therapeutics
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $48.85
Upside: +2.35%
CRISPR Therapeutics AG
Jul 22, 2025
Maintains: Buy
Price Target: $79 → $78
Current: $53.07
Upside: +46.98%
Royalty Pharma
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $36.88
Upside: +13.88%
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $48.88
Upside: +10.47%
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $56.23
Upside: +28.05%
NewAmsterdam Pharma Company
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $24.32
Upside: +72.70%
Arcellx
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $71.51
Upside: +53.82%
Amylyx Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $12
Current: $8.03
Upside: +49.44%
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.41
Upside: +183.69%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $8.74
Upside: -31.35%
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $44.34
Upside: +69.15%
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $591.01
Upside: +9.98%
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $209.15
Upside: -1.98%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $42.35
Upside: +3.90%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $111.30
Upside: +25.79%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $1.61
Upside: -37.89%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $26.89
Upside: +48.75%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $33.21
Upside: +20.45%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $36.02
Upside: +163.74%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $9.10
Upside: +174.73%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $57.96
Upside: +77.71%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $5.04
Upside: -20.63%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $118.73
Upside: +5.28%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $394.36
Upside: +45.81%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $705.44
Upside: +55.93%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $10.65
Upside: +87.79%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $10.24
Upside: +202.73%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $84.66
Upside: +71.27%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $178.84
Upside: -4.94%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $24.87
Upside: +93.00%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $48.26
Upside: +24.33%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $4.36
Upside: +221.10%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.45
Upside: +46.79%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.53
Upside: +3,110.58%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $25.38
Upside: +77.30%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.85
Upside: +1,197.30%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $4.19
Upside: -4.53%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.46
Upside: +1,817.81%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.55
Upside: +6,138.53%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $8.52
Upside: +557.28%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $2.05
Upside: +1,607.32%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.38
Upside: +15,433.00%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.48
Upside: +2,737.84%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $7.56
Upside: +164.55%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.54
Upside: +3,603.70%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $5.11
Upside: +76.13%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $8.07
Upside: +643.49%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.32
Upside: +62.04%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $14.32
Upside: +60.61%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $86.20
Upside: -4.87%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $306.48
Upside: -69.00%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.80
Upside: +716.33%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $133.23
Upside: +1.33%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $8.52
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $1.10
Upside: +1,718.18%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $14.70
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $458.31
Upside: -65.53%